JP2002530343A - 感染症の治療のためのホスホノ蟻酸誘導体の使用 - Google Patents

感染症の治療のためのホスホノ蟻酸誘導体の使用

Info

Publication number
JP2002530343A
JP2002530343A JP2000583536A JP2000583536A JP2002530343A JP 2002530343 A JP2002530343 A JP 2002530343A JP 2000583536 A JP2000583536 A JP 2000583536A JP 2000583536 A JP2000583536 A JP 2000583536A JP 2002530343 A JP2002530343 A JP 2002530343A
Authority
JP
Japan
Prior art keywords
residue
alkyl
bacteria
group
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000583536A
Other languages
English (en)
Japanese (ja)
Inventor
ヨマー、ハッサン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Jomaa Pharmaka GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka GmbH filed Critical Jomaa Pharmaka GmbH
Publication of JP2002530343A publication Critical patent/JP2002530343A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
JP2000583536A 1998-11-25 1999-11-20 感染症の治療のためのホスホノ蟻酸誘導体の使用 Pending JP2002530343A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19854310.7 1998-11-25
DE19854310A DE19854310A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
PCT/EP1999/008964 WO2000030653A2 (de) 1998-11-25 1999-11-20 Verwendung von phosphonoameisensäurederivaten zur behandlung von infektionen

Publications (1)

Publication Number Publication Date
JP2002530343A true JP2002530343A (ja) 2002-09-17

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000583536A Pending JP2002530343A (ja) 1998-11-25 1999-11-20 感染症の治療のためのホスホノ蟻酸誘導体の使用

Country Status (16)

Country Link
EP (1) EP1133302A2 (no)
JP (1) JP2002530343A (no)
CN (1) CN1328464A (no)
AP (1) AP2001002164A0 (no)
AU (1) AU1859100A (no)
BR (1) BR9915605A (no)
CA (1) CA2352511A1 (no)
CZ (1) CZ20011819A3 (no)
DE (1) DE19854310A1 (no)
EA (1) EA200100585A1 (no)
IL (1) IL142775A0 (no)
NO (1) NO20012540L (no)
OA (1) OA11718A (no)
PL (1) PL348354A1 (no)
TR (1) TR200101431T2 (no)
WO (1) WO2000030653A2 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006520374A (ja) * 2003-03-14 2006-09-07 エピスタム リミテッド 非ウィルス性上皮損傷の治療および／または予防

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453817C (en) 2001-07-20 2011-09-20 Bioagency Ag Organophosphorus compounds for the activation of gamma/delta t-cells
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (zh) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 白桦脂酸在制备抗真菌生物被膜药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5722694A (en) * 1993-11-05 1995-05-23 Astra Aktiebolag Novel amino acid derivatives
SE9604582D0 (sv) * 1996-12-13 1996-12-13 Astra Ab Novel compounds
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
DE19859668A1 (de) * 1998-06-24 1999-12-30 Hassan Jomaa Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006520374A (ja) * 2003-03-14 2006-09-07 エピスタム リミテッド 非ウィルス性上皮損傷の治療および／または予防

Also Published As

Publication number Publication date
CZ20011819A3 (cs) 2001-12-12
WO2000030653A2 (de) 2000-06-02
AP2001002164A0 (en) 2001-06-30
OA11718A (en) 2005-01-26
NO20012540D0 (no) 2001-05-23
CN1328464A (zh) 2001-12-26
PL348354A1 (en) 2002-05-20
BR9915605A (pt) 2001-08-14
NO20012540L (no) 2001-07-24
CA2352511A1 (en) 2000-06-02
IL142775A0 (en) 2002-03-10
AU1859100A (en) 2000-06-13
WO2000030653A3 (de) 2000-11-16
EP1133302A2 (de) 2001-09-19
TR200101431T2 (tr) 2001-10-22
DE19854310A1 (de) 2000-06-29
EA200100585A1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
EP1071409B1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
KR20010070962A (ko) 유기 인 화합물 및 이의 용도
US6638957B1 (en) Use of compounds with a nitrogen-oxygen heterocycle
JP2002530326A (ja) 感染症の治療のためのホスホノ蟻酸誘導体の使用
WO2000044359A2 (de) Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen
AU754378B2 (en) Organophosphorous compounds and the use thereof
JP2002530343A (ja) 感染症の治療のためのホスホノ蟻酸誘導体の使用
JP2002535354A (ja) 感染症の予防および治療処置のための有機リン化合物の使用
DE19859426A1 (de) Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
JP2003520760A (ja) 感染症の治療および予防処置用医薬製剤の製造のための、または植物における殺真菌剤、殺菌剤もしくは除草剤としての使用
JP2004505011A (ja) 感染治療のための有機リン化合物の使用
JP2002534440A (ja) 感染症の治療のための３−イソキサゾリジノンおよびヒドロキシルアミン酸の使用
ZA200105007B (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections.
DE19843360A1 (de) Phosphororganische Verbindungen und ihre Verwendung
EP0974353B1 (en) The use of homocysteine derivatives for the treatment of bacterial infections

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040803

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050104